메뉴 건너뛰기
Diabetes Care
Volumn 33, Issue 8, 2010, Pages
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: Comment on the study by Liu et al.
Author keywords

[No Author keywords available]
Indexed keywords

INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;
EID: 77958157740     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0596     Document Type: Letter
Times cited : (14)
References (5)
  • 1
    • 74249088976 scopus 로고    scopus 로고
    • Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients
    • Liu L, Zheng T, Wang F, Wang N, Song Y, Li M, Li L, Jiang J, Zhao W. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2010;33:144-149
    • (2010) Diabetes Care , vol.33 , pp. 144-149
    • Liu, L.1    Zheng, T.2    Wang, F.3    Wang, N.4    Song, Y.5    Li, M.6    Li, L.7    Jiang, J.8    Zhao, W.9
  • 2
    • 0345275787 scopus 로고    scopus 로고
    • The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
    • Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes 2003;52:3010-3013
    • (2003) Diabetes , vol.52 , pp. 3010-3013
    • Caramori, M.L.1    Canani, L.H.2    Costa, L.A.3    Gross, J.L.4
  • 3
    • 0036320727 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study
    • Berlin Diabetes Mellitus (BeDiaM) Study
    • Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E, Berlin Diabetes Mellitus (BeDiaM) Study. Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002;51:2653-2657
    • (2002) Diabetes , vol.51 , pp. 2653-2657
    • Herrmann, S.M.1    Ringel, J.2    Wang, J.G.3    Staessen, J.A.4    Brand, E.5
  • 4
    • 73249137608 scopus 로고    scopus 로고
    • Impact of the PPAR-γ2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: Evidence from BENEDICT
    • BENEDICT Study Group
    • De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P, BENEDICT Study Group. Impact of the PPAR-γ2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT. Diabetes 2009;58:2920-2929
    • (2009) Diabetes , vol.58 , pp. 2920-2929
    • De Cosmo, S.1    Motterlini, N.2    Prudente, S.3    Pellegrini, F.4    Trevisan, R.5    Bossi, A.6    Remuzzi, G.7    Trischitta, V.8    Ruggenenti, P.9
  • 5
    • 60549085974 scopus 로고    scopus 로고
    • Role of PPARγ in renoprotection in type 2 diabetes: Molecular mechanisms and therapeutic potential
    • Lond
    • Yang J, Zhang D, Li J, Zhang X, Fan F, Guan Y. Role of PPARγ in renoprotection in type 2 diabetes: molecular mechanisms and therapeutic potential. Clin Sci (Lond) 2009;116:17-26
    • (2009) Clin Sci , vol.116 , pp. 17-26
    • Yang, J.1    Zhang, D.2    Li, J.3    Zhang, X.4    Fan, F.5    Guan, Y.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.